Fortress Biotech Financials
| FBIOP Preferred Stock | USD 5.18 0.06 1.17% |
Fortress |
Understanding current and past Fortress Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Fortress Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Fortress Biotech's assets may result in an increase in income on the income statement.
Fortress Biotech Preferred Stock Summary
Fortress Biotech competes with Checkpoint Therapeutics, Mustang Bio, Reviva Pharmaceuticals, Kodiak Sciences, and Fortress Biotech. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Preferred Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US34960Q2084 |
| CUSIP | 34960Q208 |
| Location | New York; U.S.A |
| Business Address | 1111 Kane Concourse, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.fortressbiotech.com |
| Phone | 781 652 4500 |
| Currency | USD - US Dollar |
Fortress Biotech Key Financial Ratios
Fortress Biotech's financial ratios allow both analysts and investors to convert raw data from Fortress Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Fortress Biotech over time and compare it to other companies across industries.Fortress Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fortress Biotech's current stock value. Our valuation model uses many indicators to compare Fortress Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fortress Biotech competition to find correlations between indicators driving Fortress Biotech's intrinsic value. More Info.Fortress Biotech Pref is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fortress Biotech's earnings, one of the primary drivers of an investment's value.Fortress Biotech Pref Systematic Risk
Fortress Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Fortress Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Fortress Biotech Pref correlated with the market. If Beta is less than 0 Fortress Biotech generally moves in the opposite direction as compared to the market. If Fortress Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fortress Biotech Pref is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fortress Biotech is generally in the same direction as the market. If Beta > 1 Fortress Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Fortress Biotech November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Fortress Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Fortress Biotech Pref. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fortress Biotech Pref based on widely used predictive technical indicators. In general, we focus on analyzing Fortress Preferred Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fortress Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 16.27 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 3.13 |
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.